Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

6 Jan 2005 09:33

XKO Group PLC06 January 2005 XKO Group Plc 6 January 2005 XKO Group plc ("the Company") DISCLOSURE OF INTEREST IN SHARES XKO Group plc received notification on 5 January 2005 that Arlington Group plcdisposed of 1 million ordinary shares in the Company at a price of 75.5p.Arlington Group plc now holds 1.5 million ordinary shares in XKO Group plcequating to 5.43% of the Company. This is based on an issued share capital of27,648,314. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.